# About GHK-Cu Field Guide: An Independent Research Digest

> GHK-Cu Field Guide is an independent editorial project publishing plain-language summaries of the peer-reviewed GHK-Cu copper peptide literature. Not a clinic, not a vendor.

## What This Site Is

GHK-Cu Field Guide is an independent editorial project that publishes plain-language summaries of the peer-reviewed research literature on GHK-Cu — the copper(II) tripeptide glycyl-L-histidyl-L-lysine studied across five decades for collagen synthesis, skin repair, hair follicle stimulation, and gene-expression modulation.

We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The name "Field Guide" describes our editorial position relative to the literature — we organize, explain, and cite the published research for a general reader audience. Every quantitative claim on this site cites the study that measured it. Where the evidence is strong, we say so. Where it is limited — small trials, rodent-only data, industry-sponsored results, or claims awaiting independent replication — we say that too.

## What We Cover and Why

GHK-Cu sits at an unusual intersection: a molecule with more than 50 peer-reviewed publications and a well-characterized mechanism that is also widely discussed in skincare, biohacker, and research-peptide communities — often without accurate citation.

This site exists to make the actual research accessible. The literature covers six domains — skin collagen and matrix remodeling, hair follicle biology, gene-expression modulation, lung and gut tissue protection, skeletal muscle, and cognitive aging — and each has its own chapter here, color-coded for navigation. Every claim is cited. Every citation links to PubMed or PMC.

## Editorial Standards

Every quantitative claim on this site must trace to a citation in the references. We do not write dose recommendations for humans. We describe what was administered to which species at which dose by which route.

We document the limitations of the evidence as prominently as the findings. The most cited limitation in the GHK-Cu literature — that Loren Pickart is both the compound's discoverer and the primary author of most key reviews — is acknowledged wherever the Pickart 2014, 2015, 2017, and 2018 papers are cited.

We do not link to vendors, product pages, or other portfolio sites. We do not use competitor brand names. We do not make prescriptive recommendations.

---

Plain-language summaries of the peer-reviewed copper-peptide record — cited study by study, chapter by chapter, sold by no one.